Latest News
FDA approval streamlines access to Bristol Myers Squibb CAR T cell therapies
27 June 2025 - Biopharmaceutical company Bristol Myers Squibb (NYSE:BMY) announced late Thursday that the US Food and Drug Administration has approved updated labels for its two CAR T cell therapies, reducing patient monitoring requirements and remov...
Porton Advanced signs MOU with EVA Pharma for expanded Middle East and Africa CAR T-cell therapy access
27 June 2025 - Porton Advanced Solutions, a US-based global cell and gene therapy CDMO service provider, and EVA Pharma, an Egypt-based pharmaceutical company, announced on Thursday the signing of Memorandum of Understanding (MOU) to collaborate on e...
Emmaus Life Sciences' Endari label enhancements receive US FDA approval
27 June 2025 - US biopharmaceutical company Emmaus Life Sciences Inc (OTCQB:EMMA) announced on Thursday that it has received US Food and Drug Administration (FDA) approval for changes to the labelling of Endari to reflect additional prescribing infor...
WuXi AppTec's Nantong site receives 2025 Architizer A+Award
27 June 2025 - WuXi AppTec, a China-based global company that provides R&D and manufacturing services for the pharmaceutical and life science industries, announced on Thursday that its Nantong site (Phase I) has been recognised as the Popular Cho...
MGI partners with Negedia to enhance genomic sequencing in Italy
27 June 2025 - Chinese biotechnology company MGI Tech Co Ltd announced on Thursday that it has formed a partnership with Negedia, an Italian initiative born from Fondazione Telethon, to expand access to DNBSEQ-powered genomic sequencing and Stereo-se...